Update on diabetes mellitus

Murray Korc

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Diabetes mellitus is a complex multi-system disorder that may be classified as autoimmune mediated type 1 diabetes, or as insulin resistance associated type 2 diabetes. In type 1 diabetes, there is selective loss of the beta cells within the endocrine islets, as a consequence of T-cell and cytokine mediated destruction of these cells, perhaps in conjunction with destruction of the peri-islet Schwann cells. In type 2 diabetes, the etiology of the resistance ranges from post-receptor defects in the insulin signaling pathway to excessive production of adipocyte derived cytokines that antagonize insulin action to mitochondrial defects that interfere with glucose disposal. Proteome based technologies are providing new insights into these defects.

Original languageEnglish (US)
Pages (from-to)161-165
Number of pages5
JournalDisease Markers
Volume20
Issue number3
StatePublished - 2004
Externally publishedYes

Fingerprint

Medical problems
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Diabetes Mellitus
Cytokines
Endocrine Cells
Schwann Cells
Proteome
Islets of Langerhans
Adipocytes
Insulin Resistance
Insulin
Defects
Technology
T-Lymphocytes
Glucose
T-cells
Cells
Defect in Insulin Receptor

Keywords

  • Beta cell
  • Insulin resistance
  • Mitochondrial defects
  • Pancreatic cancer

ASJC Scopus subject areas

  • Medicine(all)
  • Clinical Biochemistry

Cite this

Korc, M. (2004). Update on diabetes mellitus. Disease Markers, 20(3), 161-165.

Update on diabetes mellitus. / Korc, Murray.

In: Disease Markers, Vol. 20, No. 3, 2004, p. 161-165.

Research output: Contribution to journalArticle

Korc, M 2004, 'Update on diabetes mellitus', Disease Markers, vol. 20, no. 3, pp. 161-165.
Korc M. Update on diabetes mellitus. Disease Markers. 2004;20(3):161-165.
Korc, Murray. / Update on diabetes mellitus. In: Disease Markers. 2004 ; Vol. 20, No. 3. pp. 161-165.
@article{f8176ccb798e4b66bd296b0b104dbb09,
title = "Update on diabetes mellitus",
abstract = "Diabetes mellitus is a complex multi-system disorder that may be classified as autoimmune mediated type 1 diabetes, or as insulin resistance associated type 2 diabetes. In type 1 diabetes, there is selective loss of the beta cells within the endocrine islets, as a consequence of T-cell and cytokine mediated destruction of these cells, perhaps in conjunction with destruction of the peri-islet Schwann cells. In type 2 diabetes, the etiology of the resistance ranges from post-receptor defects in the insulin signaling pathway to excessive production of adipocyte derived cytokines that antagonize insulin action to mitochondrial defects that interfere with glucose disposal. Proteome based technologies are providing new insights into these defects.",
keywords = "Beta cell, Insulin resistance, Mitochondrial defects, Pancreatic cancer",
author = "Murray Korc",
year = "2004",
language = "English (US)",
volume = "20",
pages = "161--165",
journal = "Disease Markers",
issn = "0278-0240",
publisher = "IOS Press",
number = "3",

}

TY - JOUR

T1 - Update on diabetes mellitus

AU - Korc, Murray

PY - 2004

Y1 - 2004

N2 - Diabetes mellitus is a complex multi-system disorder that may be classified as autoimmune mediated type 1 diabetes, or as insulin resistance associated type 2 diabetes. In type 1 diabetes, there is selective loss of the beta cells within the endocrine islets, as a consequence of T-cell and cytokine mediated destruction of these cells, perhaps in conjunction with destruction of the peri-islet Schwann cells. In type 2 diabetes, the etiology of the resistance ranges from post-receptor defects in the insulin signaling pathway to excessive production of adipocyte derived cytokines that antagonize insulin action to mitochondrial defects that interfere with glucose disposal. Proteome based technologies are providing new insights into these defects.

AB - Diabetes mellitus is a complex multi-system disorder that may be classified as autoimmune mediated type 1 diabetes, or as insulin resistance associated type 2 diabetes. In type 1 diabetes, there is selective loss of the beta cells within the endocrine islets, as a consequence of T-cell and cytokine mediated destruction of these cells, perhaps in conjunction with destruction of the peri-islet Schwann cells. In type 2 diabetes, the etiology of the resistance ranges from post-receptor defects in the insulin signaling pathway to excessive production of adipocyte derived cytokines that antagonize insulin action to mitochondrial defects that interfere with glucose disposal. Proteome based technologies are providing new insights into these defects.

KW - Beta cell

KW - Insulin resistance

KW - Mitochondrial defects

KW - Pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=4744342864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4744342864&partnerID=8YFLogxK

M3 - Article

C2 - 15502249

AN - SCOPUS:4744342864

VL - 20

SP - 161

EP - 165

JO - Disease Markers

JF - Disease Markers

SN - 0278-0240

IS - 3

ER -